All In Biotech

Free tool

FAERS Monitor: Roxybond

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209777 or its brand name (Roxybond, Oxycodone Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

84,853

Serious

74,866

88% of reports

Hospitalization

14,871

Death reported

30,340

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug dependence24,868
  • pain18,004
  • overdose16,632
  • emotional distress14,587
  • death13,667
  • toxicity to various agents12,576
  • drug withdrawal syndrome9,399
  • drug ineffective3,854
  • fatigue3,790
  • drug abuse3,468
  • nausea3,359
  • off label use2,744
  • dyspnoea2,641
  • rash2,641
  • anxiety2,626

Reports by year received

View as table
YearReports
200413
200514
200632
200754
200896
200984
2010112
2011144
2012437
2013596
2014541
2015724
20162,142
20173,956
201824,810
20192,873
20204,715
202112,661
202215,115
20234,326
20244,016
20254,270
20263,122

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,969,306 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug dependenceSignal24,86845.244.6914,880
emotional distressSignal14,58733.833.3410,953
drug withdrawal syndromeSignal9,39929.629.0232,993
overdoseSignal16,63220.620.3289,583
toxicity to various agentsSignal12,57619.919.6210,507
drug abuseSignal3,46810.710.429,439
painSignal18,0047.57.4100,595
deathSignal13,6674.03.931,283
anxietySignal2,6262.32.21,935
rash2,6411.51.4454
fatigue3,7901.21.2140
dyspnoea2,6411.21.157
nausea3,3591.11.09
off label use2,7440.80.7184
drug ineffective3,8540.70.7431

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.